Molecular biology of exocrine pancreatic cancer

José Luis Soto, Víctor Manuel Barbera, Miguel Saceda, Alfredo Carrato

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Exocrine pancreatic cancer is one of the neoplasias with a worse prognosis, with conventional treatments having little impact on disease outcome. Research and genomic high-throughput technology is continuously expanding our knowledge of pancreas cancer biology. Characterization of genetic and epigenetic alterations in pancreatic tumors has allowed a better understanding of the progression model of the disease at the molecular level. The development of new therapeutic approaches with target-oriented agents is been tested in the preclinical and clinical settings. This review updates the current available data on pancreatic cancer molecular biology.

Original languageEnglish
Pages (from-to)306-312
Number of pages7
JournalClinical and Translational Oncology
Issue number5
StatePublished - 2006


  • Genetic alterations
  • Molecular biology
  • New drugs
  • Pancreatic cancer


Dive into the research topics of 'Molecular biology of exocrine pancreatic cancer'. Together they form a unique fingerprint.

Cite this